Full-Time

Research Associate Scientist

Inflammation Discovery Research

Posted on 3/13/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$96.6k - $151.8kAnnually

+ Short-term Incentives + Long-term Incentives

Mid, Senior

Boston, MA, USA

This position is currently classified as 'onsite' in Cambridge, MA.

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • MS in a scientific discipline with 3+ years’ experience, or BS with 5+ years’ experience
  • Expertise in at least one of the following assay methods: ELISA/MSD, Western blot, qPCR, flow cytometry, ChIP
  • Experience with cell culture, including isolation, culture, and analysis of primary immune cell subsets
  • Direct experience with the principles, models, and pathways of autoimmunity, inflammation, and/or fibrosis
  • Experience developing and/or evaluating small molecule, biologic and/or nucleic acid therapeutics
  • Demonstrates strong organizational and project management skills and effective written and verbal communication skills.
Responsibilities
  • Generate data packages supporting candidate selection and asset characterization based on current in vitro methods including immortalized cell lines, primary cell cultures, and multicellular or organoid culture models, preferably models that recapitulate cellular cross-talk in fibroinflammatory or diseased tissues
  • Champion scientific integrity and rigor in preparation and interpretation of detailed protocols/SOPs
  • Independently plans assignments for a research work group or project, troubleshoots complex problems specialized procedures, and change experimental design if necessary
  • Develops and validates new methods to support completion of complex assignments within a project
  • Exercises independent judgment (selecting most appropriate methods, coordinating efforts, evaluating criteria for obtaining results)
  • Utilizes technical literature to implement novel procedures, changes, and improvements within a project. Can duplicate and appropriately modify experimental procedures based on the literature
  • Interprets and analyzes data, helping to incorporate results into overall scientific projects; Independently generates novel hypotheses
  • Maintains a proactive and vocal approach to improving departmental efficiency
  • Able to summarize and present literature data within the department and occasionally to a broader audience.
Desired Qualifications
  • Preferred: familiarity with in vivo study design/execution; modern high-dimensional gene expression analysis (i.e., scRNAseq); multicellular culture systems (i.e., organoids)

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and commercialize them, with a goal of launching up to 15 new products by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to provide life-changing therapies while ensuring that patient needs are prioritized and environmental risks are managed.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...